Monkey stem cells may lead to Parkinson's treatment.
Previously, Yoshiki Sasai, PhD and colleagues from Kyoto University had used their technique, called stromal cell-derived inducing activity (SDIA), to get stem cells of mice to differentiate into dopamine-producing neurons. Next, the team plans to transplant SDIA-derived neurons into the brains of monkeys.
Sasai said the SDIA technique offers "a practical alternative" to controversial fetal tissue transplants that occasionally are used to treat Parkinson's. And he noted in the February 5 issue of the Proceedings of the National Academy of Sciences, that the benefits of the research may not be limited to that disease. An unexpected outcome of the work was that the researchers were able to make pigmented epithelium, a tissue that forms the outermost layer of the retina. This tissue, according to Sasai, might be used to treat retinitis pigmentosa, a degenerative eye disease that leads to blindness.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||according to research from Kyoto University|
|Comment:||Monkey stem cells may lead to Parkinson's treatment.(according to research from Kyoto University)|
|Article Type:||Brief Article|
|Date:||Feb 14, 2002|
|Previous Article:||Cloned fetal cow cells create kidney-like organ that works when transplanted.|
|Next Article:||AMA to challenge member to get more involved in organ donation process.|